IBA is partnering with Elekta to exclusively present the Monaco® for Proton Therapy Solution2 and the latest innovation in Oncology informatics, including enhancements to proton workflows. Together, we will enable precise and personalized radiotherapy to every patient in the world.

Discover Elekta’s demo at IBA booth #3028 here.

IBA and RaySearch integration

IBA and RaySearch will present their fully integrated patient workflow solution, currently being installed at UZ Leuven, Belgium, combining the RayCare® 3 oncology information system, RayStation® treatment planning system, AdaPT Insight imaging platform, and AdaPT Deliver treatment delivery.

Discover RaySearch’s demos at IBA booth #3028 here.


About IBA
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,400 people worldwide, IBA has installed systems across the world.

IBA is listed on the pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at iba-worldwide.com

1 Arc therapy is work in progress and Flash therapy is currently under research. They are not available for sale.

2 Monaco® for Proton Therapy is future technology requiring FDA 510(k) and not available for sale in any market

3 Subject to regulatory clearance in some markets

Back to HCB News

Rad Oncology Homepage